{
    "clinical_study": {
        "@rank": "72059", 
        "acronym": "SiCDIP", 
        "arm_group": [
            {
                "arm_group_label": "Celsite", 
                "arm_group_type": "Active Comparator", 
                "description": "patients received celsite chemoport implantation under local anesthesia"
            }, 
            {
                "arm_group_label": "Humanport", 
                "arm_group_type": "Experimental", 
                "description": "patients received Humanport chemoport implantation under local anesthesia"
            }
        ], 
        "brief_summary": {
            "textblock": "To compare the performance of domestic chemoport and imported chemoport"
        }, 
        "brief_title": "Single-center Randomized Trial for Comparison of Performance Between Domestic and Imported Chemoport", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Cancer", 
        "detailed_description": {
            "textblock": "chemoport implantation was done by two investigator Chemoport type was randomly rendered.\n      Domestic chemoport(Human port) and imported chemoport (Celsite) were used. chemoport\n      function will be followed up."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients who will receive chemotherapy via implantable port\n\n          -  age >20 years\n\n          -  expected life time > 6 months\n\n          -  lab test (platelet>50K, PT INR <2.0)\n\n        Exclusion Criteria:\n\n          -  performance status >2\n\n          -  brain metastasis\n\n          -  expected life time less than 6 months\n\n          -  age less than 20 years\n\n          -  active infection\n\n          -  severe heart dysfunction\n\n          -  recent myocardial infarct"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "176", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01733342", 
            "org_study_id": "HP2012-k"
        }, 
        "intervention": [
            {
                "arm_group_label": "Celsite", 
                "description": "Celsite chemoport implantation was done under local anesthesia, at anterior chest wall, under ultrasound guidance", 
                "intervention_name": "Celsite chemoport implantation", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "Celsite", 
                    "Humanport"
                ], 
                "description": "chemoport implantation will be done under local anesthesia using lidocaine.", 
                "intervention_name": "local anesthesia", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Humanport", 
                "description": "Humanport chemoport implantation was done under local anesthesia, at anterior chest wall, under ultrasound guidance", 
                "intervention_name": "Humanport chemoport implantation", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Anesthetics"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 2, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Seoul National University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Single-center Randomized Trial for Comparison of Performance Between Domestic and Imported Chemoport", 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Hyo-Cheol Kim, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Ministry of Education, Science, and Technology", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Whether or not chemoport function is intact will be assessed. Chemoport function will be rendered as intact when chemotherapeutic agent is well infused through the chemoport. Chemoport function will be rendered as not intact when chemotherapeutic agent could be infused through the chemoport.", 
            "measure": "function of chemoport", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "reference": [
            {
                "PMID": "7123491", 
                "citation": "Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery. 1982 Oct;92(4):706-12."
            }, 
            {
                "PMID": "22563269", 
                "citation": "Ahn SJ, Kim HC, Chung JW, An SB, Yin YH, Jae HJ, Park JH. Ultrasound and fluoroscopy-guided placement of central venous ports via internal jugular vein: retrospective analysis of 1254 port implantations at a single center. Korean J Radiol. 2012 May-Jun;13(3):314-23. doi: 10.3348/kjr.2012.13.3.314. Epub 2012 Apr 17."
            }, 
            {
                "PMID": "21207035", 
                "citation": "Teichgr\u00e4ber UK, Kausche S, Nagel SN, Gebauer B. Outcome analysis in 3,160 implantations of radiologically guided placements of totally implantable central venous port systems. Eur Radiol. 2011 Jun;21(6):1224-32. doi: 10.1007/s00330-010-2045-7. Epub 2011 Jan 5."
            }, 
            {
                "PMID": "21534232", 
                "citation": "Teichgr\u00e4ber UK, Kausche S, Nagel SN. Evaluation of radiologically implanted central venous port systems explanted due to complications. J Vasc Access. 2011 Oct-Dec;12(4):306-12. doi: 10.5301/JVA.2011.7739."
            }, 
            {
                "PMID": "9739444", 
                "citation": "Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nol\u00e8 F, Andreoni B. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol. 1998 Jul;9(7):767-73."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01733342"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Hyo-Cheol Kim", 
            "investigator_title": "Clinical Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "If infection related with chemoport develop during 6 month follow-up, infection will be recorded.", 
                "measure": "infection", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "If skin dehiscence related with chemoport develop during 6 month follow-up, it will be recorded.", 
                "measure": "Skin dehiscence", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "If deep vein thrombosis related with chemoport develop during 6 month follow-up, it will be recorded. Deep vein thrombosis can be develop in the jugular vein which is access route.", 
                "measure": "deep vein thrombosis", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "If fibrin sheath around chemoport catheter develop during 6 month follow-up, it will be recorded.", 
                "measure": "Fibrin sheath", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}